Innovative inhibitor to combat obesity and heart diseaseAn interdisciplinary research team at The University of Texas at San Antonio has successfully developed an innovative inhibitor that...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure1 day ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity1 day ago